Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TGF-β1 decreases CHOP expression and prevents cardiac fibroblast apoptosis induced by endoplasmic reticulum stress.

Toxicology in vitro : an international journal published in association with BIBRA·2020
Same author

4-Phenylbutyric acid prevent cytotoxicity induced by thapsigargin in rat cardiac fibroblast.

Toxicology in vitro : an international journal published in association with BIBRA·2014
Same author

Whole-Genome Sequencing and Comparative Analysis of Yersinia pestis, the Causative Agent of a Plague Outbreak in Northern Peru.

Genome announcements·2013
Same author

[Abdominal pain].

Revista paulista de medicina·2010
Same author

[Evolution of the darbepoetin alpha resistance index in patients on dialysis who change from weekly to fortnightly treatments in clinical practice].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2010
Same author

[Phosphorus (P) chelant in dialysis: efficacy and cost. Peritoneal dialysis solutions].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2008
Same journal

[Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2024
Same journal

[Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?]

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

[Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

[Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

Acute interstitial nephritis following COVID-19 vaccination.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2022
See all related articles

Related Experiment Video

Updated: Jun 29, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

[Peritoneal dialysis solutions].

J Montenegro1

  • 1Jefe del Servicio de Nefrologia, Hospital de Galdakao, Vizcaya, Spain.

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|October 14, 2008
PubMed
Summary
This summary is machine-generated.

New peritoneal dialysis solutions show mixed results for kidney function and inflammation. While some biocompatible options may reduce inflammation, evidence for improved kidney preservation and ultrafiltration remains inconsistent, requiring further research.

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jun 29, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

Area of Science:

  • Nephrology
  • Biomaterials Science

Background:

  • Peritoneal dialysis (PD) is a crucial renal replacement therapy.
  • Novel PD solutions are being developed to improve patient outcomes.
  • Existing literature presents conflicting data on the efficacy of new PD solutions.

Purpose of the Study:

  • To review and synthesize the current evidence on the clinical benefits of new peritoneal dialysis solutions.
  • To identify areas of consensus and conflict regarding the effects of these solutions on patient health.

Main Methods:

  • Systematic review of recent publications on new peritoneal dialysis solutions.
  • Analysis of reported clinical outcomes, including kidney function, inflammation markers, peritonitis incidence, and ultrafiltration.
  • Comparison of biocompatible solutions (bicarbonate, lactate, bicarbonate/lactate) with standard solutions.

Main Results:

  • Biocompatible bicarbonate solutions may improve kidney function preservation, unlike lactate-based ones.
  • Lower C-reactive protein (CRP) levels are reported with biocompatible solutions, though findings vary.
  • Newer solutions generally show reduced peritoneal inflammation and potentially lower peritonitis rates.
  • Ultrafiltration (UF) effects are debated, with some studies indicating a decrease with new solutions.
  • Higher glucose degradation products correlate with increased levels in peritoneal fluid and blood, promoting advanced glycosylation.

Conclusions:

  • Evidence for the clinical benefits of new peritoneal dialysis solutions is not yet conclusive.
  • Conflicting reports necessitate further well-designed, controlled studies to validate efficacy.
  • Understanding the impact of glucose degradation products is critical for optimizing PD solution safety and effectiveness.